![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24886-24892, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Laboratory of Cell Biology, NHLBI, National Institutes of
Health, Bethesda, Maryland 20892
Received for publication, May 18, 2000
Acanthamoeba myosin IC has a single
129-kDa heavy chain and a single 17-kDa light chain. The heavy chain
comprises a 75-kDa catalytic head domain with an ATP-sensitive
F-actin-binding site, a 3-kDa neck domain, which binds a single 17-kDa
light chain, and a 50-kDa tail domain, which binds F-actin in the
presence or absence of ATP. The actin-activated MgATPase activity of
myosin IC exhibits triphasic actin dependence, apparently as a
consequence of the two actin-binding sites, and is regulated by
phosphorylation of Ser-329 in the head. The 50-kDa tail consists of a
basic domain, a glycine/proline/alanine-rich (GPA) domain, and a
Src homology 3 (SH3) domain, often referred to as tail
homology (TH)-1, -2, and -3 domains, respectively. The SH3 domain
divides the TH-3 domain into GPA-1 and GPA-2. To define the functions
of the tail domains more precisely, we determined the properties of
expressed wild type and six mutant myosins, an SH3 deletion mutant and
five mutants truncated at the C terminus of the SH3, GPA-2, TH-1, neck and head domains, respectively. We found that both the TH-1 and GPA-2
domains bind F-actin in the presence of ATP. Only the mutants that
retained an actin-binding site in the tail exhibited triphasic actin-dependent MgATPase activity, in agreement with the
F-actin-cross-linking model, but truncation reduced the MgATPase
activity at both low and high actin concentrations. Deletion of the SH3
domain had no effect. Also, none of the tail domains, including the SH3
domain, affected either the Km or
Vmax for the phosphorylation of Ser-329 by
myosin I heavy chain kinase.
The myosin superfamily includes more than 120 different isoforms
falling into 15 classes based on the sequences of their catalytic domains and also differing in the structure of their tails (1). Other
than the conventional class II myosins, class I myosins are the most
numerous, most widely distributed, and most extensively studied. At
this writing, the complete DNA sequences of the heavy chains of
30 class I myosins from 13 species including yeast, protozoa,
invertebrates, and vertebrates have been determined. The structure,
enzymatic properties, and possible functions of many of the class I
myosins have been investigated, none more extensively than the three
Acanthamoeba myosin Is (IA, IB, and IC), which were the
first unconventional (nonclass II) myosins to be discovered (2).
All class I myosins have a single, relatively short (for myosins) heavy
chain, one or more light chains, and, unlike class-II myosins, do not
polymerize into filaments. By sequence analysis (3-5), the masses of
the heavy chains of Acanthamoeba myosin IA, IB, and IC are
134, 125, and 129 kDa, respectively, consisting of an N-terminal head
(catalytic, motor) domain of ~75 kDa, a short neck domain that binds
one (myosin IB and myosin IC (6)) or possibly as many as three (myosin
IA (5)) light chains and a nonhelical C-terminal tail domain of ~50
kDa. Only the single light chain of myosin IC has been cloned and
sequenced (7); it is a calmodulin-like protein with a mass of ~17
kDa. The tail domains have been subdivided by sequence into three
regions: a basic domain
(TH-1),1 a Gly/Pro/Ala-rich
(GPA) domain (TH-2), and a Src homology 3 domain (TH-3).
These three regions occur sequentially in Acanthamoeba myosins IA (5) and IB (4), but the TH-3 region of myosin IC splits its
C-terminal TH-2 domain in two (3). It seems highly likely that specific
interactions of these three tail domains play important roles in
determining the different localizations and different functions of the
three isozymes (8-10).
The bacterially expressed TH-1 domain of Acanthamoeba myosin
IC binds acidic phospholipids (11) and, therefore, TH-1 is almost
certainly responsible for the ability of the native myosins to bind to
acidic lipids (12) and amoeba plasma membranes (13). Experiments with
bacterially expressed TH-2 plus TH-3 domains of Acanthamoeba
myosin IC (11), with bacterially expressed TH-2 region of
Dictyostelium myosin IB (14) and with a C-terminal 30-kDa
proteolytic fragment of Acanthamoeba myosin IA (15), had
indicated that the TH-2 region may be principally responsible for the
ability of the amoeba myosin Is to bind to F-actin in the presence of
ATP (15-17). As we will discuss later (see "Discussion"), the TH-3
domain is likely to be involved in the localization of myosin Is and
the organization of the actin cytoskeleton (18).
The three Acanthamoeba myosin Is have similar catalytic
activities. All have high ATPase activity in the presence of EDTA and
either NH4+ or K+ and low activity
in the presence of Mg2+ that is substantially activated by
F-actin, a diagnostic characteristic of the myosin superfamily.
However, the MgATPase activity of these amoeba myosin Is has an
unusual triphasic dependence on the F-actin concentration (17, 19, 20),
i.e. substantial activation at low F-actin concentrations
peaking at about 2 µM, followed by a decrease in the
activity and then normal hyperbolic activation that begins to plateau
at about 80 µM F-actin. A variety of experimental data
and computer modeling strongly support the conclusion that this
triphasic actin dependence is caused by cooperative cross-linking of
actin filaments by myosin I at high ratios of myosin I to actin (17,
19, 21, 22). The ability of these myosins to cross-link actin filaments
can be explained by the presence of two actin-binding sites, the
ATP-sensitive actin-binding site in the catalytic domain that is common
to all myosins of all classes and the ATP-insensitive actin-binding
site(s) in the tail that occurs in some (but not all) class I myosins
including, in addition to the three Acanthamoeba myosin Is,
two of the five Dictyostelium myosin Is (23, 24).
The actin-activated MgATPase activities of the myosin Is from
Acanthamoeba (25), Dictyostelium (26), and
Aspergillus (27) are activated by phosphorylation of a Thr
or Ser at a position (Ser-329 in Acanthamoeba myosin IC
(28)) in a conserved actin-binding surface loop (29) where almost all
other myosins have a Glu or Asp residue (1, 30, 31). The
Acanthamoeba (32) and Dictyostelium (33) myosin I
heavy chain kinases (MIHCK) that phosphorylate the Ser and Thr residues
are members of the p21-activated kinase (Pak) family. Like other Paks,
the 97-kDa MIHCK is activated by Rac and Cdc42 (34) and lipids (35).
Only the 35-kDa C-terminal catalytic domain and a short p21-binding
domain near the N terminus of MIHCK have sequence similarity to other
Paks (34). Interestingly, the central region of MIHCK is very rich in
Pro residues, including multiple PXXP repeats
characteristic of SH3-binding domains in other proteins (34).
Therefore, it seemed possible that the TH-3 (SH3) tail subdomain of the
Acanthamoeba myosin Is might be a site for interaction with
MIHCK.
From this brief introduction, it is apparent that the three tail
subdomains have important roles in the activity and function of the
Acanthamoeba myosin Is. However, the properties of the tail
domains have been characterized mostly by studying the properties of
bacterially expressed peptides. In the work described in this paper, we
compared the properties of expressed wild type Acanthamoeba myosin IC and truncated and deletion tail mutants to define more quantitatively the actin-binding region in the tail, to confirm that
the triphasic actin dependence of the MgATPase activity is caused by
the second actin-binding site in the tail, and to evaluate the
possibility that the SH3 domain of Acanthamoeba myosin IC may interact with the Pro-rich region of MIHCK. After these studies were completed, Lee et al. (5) reported interesting results, which we will discuss later in this paper, on the actin-binding properties of bacterially expressed peptides corresponding to the TH-1
and TH-2 plus TH-3 regions of Acanthamoeba myosin IA.
Generation of Mutant cDNAs--
Standard methods were used
for all DNA manipulations (36). The myosin I heavy chain cDNA
(accession number AF051353) cloned into pBluescript plasmid (3,
6) served as the template for the PCR reactions described below. Fig. 1
shows the mutants constructed in this study.
The plasmid containing the TH-3 deletion mutant (
An intermediate vector with a unique MluI site immediately
following the myosin IC stop codon was constructed to generate all the
truncation mutants. The sense primer (primer C),
5'-GTCCTCCTCCCCCGGGTCCCTAACGCGTCCGGACCAATGC-3' (bp 3539-3579 of myosin IC), was designed to introduce a
SanDI restriction site (first underlined sequence) upstream
of the stop codon (in bold) and an MluI site (second
underlined sequence) downstream of the stop codon. The PCR was run
between sense primer C and antisense primer B, and the product was
cloned into the original plasmid digested with SanDI and
XbaI. This produced a vector containing myosin IC heavy
chain cDNA truncated at the SanDI site with an
MluI site downstream of the stop codon.
The T-2, T-3, T-4, T-5, and T-6 truncants were generated by PCR
utilizing a unique ScaI site located within the light
chain-binding region of the myosin IC heavy chain and an
MluI site of the intermediate vector. The sense primer
(primer D), 5'-CCGCGTCGTGTGCCCCAAGACCTGGTCCG-3' (bp 1881-1909) was
used to generate all the truncants. The antisense primers for each
truncation contained a stop codon (in bold) that was introduced
immediately after the truncation point and an MluI restriction site (underlined) downstream of the stop codon. The antisense primers were: for T-2,
5'-CAGGCGACGACGCACGCGTTAGTTGACGAGCGCGTCATTG-3) (bp 2142-2181); for T-3,
5'-ACGCTGATCAGCACGCGTTAGTCCTGCAGCGGGCTGAGGG-3' (bp 2471-2511); for T-4,
5'-GCCGCCGCCTCCCACGCGTAAGAGGATCTGGTCCTTGTAGG-3' (bp 2977-3012); for T-5,
5'-GTCATACAGCGCACGCACGCGTAAGGGTCCGGGCGC-3' (bp
3141-3169); for T-6, 5'-GCGCAGCGACGCGTTAGATGAGTTCGACG-3' (bp 3149-3169).
The wild type myosin IC plasmid was used as template. Each of the PCR
products was subcloned into the intermediate vector digested with
MluI and partially digested with ScaI (because
the vector DNA has a second ScaI site).
T-1 was constructed utilizing the PstI site located within
the head domain of the myosin IC heavy chain and the MluI
site in the T-2 plasmid. Primers used for PCR were: sense primer
5'-CAACTTCGTGAAGCTGCAGCAGATCTTC-3' (bp 1234-1267 of myosin
IC heavy chain), which contains a PstI site (underlined);
antisense primer
5'-GGTCTTGCGGAGGAATCTCACGCGTTAGTTGGCGTAGGAGAAC-3' (bp 2061-2103 of myosin IC), which introduced a new stop codon (in
bold) after the truncation point and an MluI site
(underlined) immediately downstream of the stop codon. The PCR product
was subcloned into pBluescript T-2 digested completely with
MluI and partially with PstI (because the vector
contains another PstI site). This produced truncated DNA
encoding T-1 (Fig. 1). The sequences of all the mutant DNAs were confirmed.
The wild type and mutant heavy chain DNAs were subcloned from
pBluescript into the expression vector PVL1393 (PharMingen) by
digestion with BamHI. A Flag epitope tag, MADYKDDDDYA, was placed at the N terminus of all of the heavy chains to provide a means
for rapid purification of the wild type and mutant myosins.
Culture of Sf-9 Cells and Production of Myosin Heavy Chain
Recombinant Viruses--
Sf-9 cells were cultured in suspension using
Grace's medium supplemented with 10% fetal calf serum (Life
Technologies, Inc.). Transfection was achieved by mixing 2-4
µg of plasmid DNA with 0.5 µg of BaculoGold vector DNA (PharMingen)
according to the protocol provided by the manufacturer. Recombinant
viruses were identified as occlusion-negative plaques. Viral stock was
amplified according to the manufacturer's protocols and kept at
4 °C. The myosin IC light chain (6), the 35K catalytic domain (32), and full-length MIHCK2 viral
stocks were prepared previously in this laboratory.
Expression and Purification of Proteins--
Wild type and
mutant myosins were produced by co-infection of Sf-9 cells (2 × 106 cells/ml) with heavy chain and light chain viral
stocks. All purification procedures were carried out at 4 °C. Wild
type and mutant myosins were purified as described previously (6) with some modification. Briefly, Sf-9 cells were harvested 48 h after infection. About 2 g of cells were homogenized in 20 ml of
extraction buffer (200 mM NaCl, 4 mM
MgCl2, 2 mM ATP, 1 mM DTT, and 10 mM Tris, pH 7.5) containing 0.1 mM
phenylmethylsulfonyl fluoride and 1 tablet of protease inhibitor
mixture (Roche Molecular Biochemicals). The lysate was centrifuged at
45,000 rpm in a Beckman T170 rotor for 1 h, and the resultant
supernatant was added to 1 ml of packed anti-FLAG antibody resin
(Sigma) that had been washed with 0.1 M glycine (pH 3.5)
and equilibrated with the extraction buffer. The resin was washed with
20 ml of extraction buffer, and myosin was eluted with 2.5 ml of
extraction buffer containing 0.15 mg/ml FLAG peptide. The eluted
fraction was concentrated about 3-fold by dialysis against 50%
glycerol, 100 mM NaCl, 1 mM DTT, and 10 mM Tris, pH 7.5. After dialysis the sample was clarified by
spinning at 15,000 rpm for 10 min at 4 °C, and the final product was
kept in liquid nitrogen until use.
The myosins were partially phosphorylated during expression in Sf-9
cells. To prepare unphosphorylated myosins for use as substrates for
MIHCK, wild type myosin IC and the T-2 mutant were dephosphorylated
while bound to the FLAG affinity resin as an added step in the
purification procedure. The resin with bound myosin was washed with
~20 volumes of extraction buffer and then with one volume of
phosphatase buffer (New England Biolabs, Beverly, MA). About 4000 units
of lambda protein phosphatase (New England Biolabs) in 1 ml of
phosphatase buffer (New England Biolabs) was added to ~1 ml of the
resin-bound myosin. Dephosphorylation was carried out at room
temperature for 15 min with occasional resuspension of the resin by
pipetting. The resin was then washed with the extraction buffer, and
myosin was eluted and collected as described above.
For expression of maximum actin-dependent MgATPase
activity, the myosins must be fully phosphorylated on Ser-329. The wild type and mutant myosins were incubated with activated
(autophosphorylated) 35K catalytic domain of MIHCK at a molar ratio of
1 to 8 in buffer containing 50 mM imidazole, pH 7.0, 2.5 mM ATP, 3.5 mM MgCl2, and 2 mM EGTA (and 50 mM NaCl and 25% glycerol
derived from the myosin storage buffer) at 30 °C for 10 min. As
determined by the incorporation of 32P from
[
The 35K catalytic domain and full-length MIHCK were purified using a
nickel-nitrilotriacetic acid resin column as described (32). Purified
kinase was dialyzed against 50% glycerol, 10 mM Tris, pH
7.5, and 1 mM DTT and kept in liquid nitrogen until use.
The kinase and 35K catalytic domain were essentially homogeneous as
determined by SDS-polyacrylamide gel electrophoresis (data not shown).
To obtain fully active, autophosphorylated kinases, the purified 35K
catalytic domain and full-length MIHCK (both at 0.2 mg/ml) were first
incubated for 30 min at 30 °C in 50 mM imidazole (pH
7.0) containing 2.5 mM ATP, 3.5 mM
MgCl2, and 2 mM EGTA and BSA (0.2 mg/ml).
Rabbit skeletal muscle actin was prepared from rabbit skeletal muscle
acetone powder according to Spudich and Watt (37). Acanthamoeba actin, which was kindly provided by Dr. Kirsten
Remmert (National Heart, Lung, and Blood Institute), was prepared as
described (38). The concentrations of myosins and kinases were
determined by the Bradford method using BSA as the standard (39). Actin concentrations were determined spectrophotometrically using an extinction coefficient of 0.62 cm2/ml at 290 nm.
Kinase Assay--
Assays were performed essentially as described
(40). The activated kinases (4.5 nM) were incubated at
30 °C for 20 s with various concentrations of dephosphorylated
wild type and T-2 mutant myosins, as substrates, in 50 mM
imidazole (pH 7.0) containing 2.5 mM
[ Actin-binding Assay--
The binding of wild type and mutant
Acanthamoeba myosin IC to F-actin was assayed in solutions
containing 10 mM Tris, pH 7.5, 3.5 mM
MgCl2, 1 mM EGTA, 0.2 mg/ml BSA, with or
without 2.5 mM ATP as indicated, and NaCl at the
concentrations indicated in the figure legends. Myosins were mixed with
various concentrations of F-actin and centrifuged for 30 min at 100,000 rpm in a Beckman TL centrifuge at 4 °C. The fraction of myosin
unbound was determined by measuring the NH4/EDTA-ATPase
activity remaining in the supernatant.
ATPase Assays--
Steady state ATPase activities were
determined at 30 °C by measuring the radioactivity of Pi
released from [ Electrophoresis--
SDS-polyacrylamide gel electrophoresis was
carried out according to Laemmli (41). The separating gel consisted of
two layers; the upper half contained 7.5% acrylamide and the lower
half contained 13% acrylamide.
Expression and Purification of Myosin IC Wild Type and
Mutants--
The 129-kDa heavy chain of myosin IC can be divided into
a head domain, residues 1-693; a light chain-binding neck domain, residues 694-720; and four tail domains: the basic TH-1 domain, residues 721-940; the TH-3 (SH3) domain, residues 997-1051; and the
two segments of the GPA TH-2 domain, GPA-1, residues 941-996, and
GPA-2, residues 1052-1186, that are separated by the SH3 domain (Fig.
1). As described under "Materials and
Methods," we constructed six truncated mutants and one deletion
mutant (Fig. 1): T-1, the head only; T-2, the head and neck; T-3, the
head, neck, and one-half of TH-1; T-4, the head, neck, and entire TH-1;
T-5, the head, neck, TH-1, and GPA-1; T-6, the head, neck, GPA-1, and
SH3; and Binding to F-actin--
We compared the binding of the wild
type and six mutant myosins to an excess of muscle F-actin in the
presence or absence of ATP. As expected, because the head domain of all
myosins has a high affinity, ATP-sensitive actin-binding site, all of
the expressed myosins bound to actin essentially quantitatively in the
absence of ATP (Fig. 3). The wild type
and
Next, we quantified the relative affinities for F-actin of wild type
myosin and the T-4, T-5, T-6, and
Lee et al. (5) reported that bacterially expressed peptide
TH-2 of Acanthamoeba myosin IA bound much more weakly to
muscle F-actin in 60 mM KCl than in the absence of KCl, but
that salt did not affect the binding of TH-2 to Acanthamoeba
F-actin and that the binding of expressed TH-1 peptide to both actins
was unaffected by the ionic strength. We found that in the presence of
ATP, i.e. when binding occurs only through the tail site(s), both T-4 and wild type bound equivalently to muscle and
Acanthamoeba F-actin. In contrast to the findings of Lee
et al. (5) for peptides, we found that the binding of both
myosins to both actins was very, and approximately equally, sensitive
to the ionic strength (Fig. 5).
ATPase Activities of Wild Type and Mutant Myosins--
The
MgATPase activities in the absence of F-actin of fully phosphorylated
(on Ser-329) wild type and the six mutant myosins were very similar,
~0.05 s
The actin dependence of the MgATPase activities of the wild type and
mutant myosins are shown in Fig. 6. Wild
type and
Albanesi et al. (21) found the triphasic actin dependence of
the MgATPase activities of the Acanthamoeba myosin Is to be a function of the molar ratio of myosin to F-actin, i.e.
activation occurs at low actin concentration when the concentration of
myosin is sufficient to cross-link cooperatively the actin filaments thus increasing the effective concentration of actin for the myosin catalytic domains. The data in Fig. 7 are
consistent with this proposal. Although, the peak specific activities
of 40 and 120 nM wild type myosin IC at low F-actin
concentration were the same, the activity peak was much narrower for 40 nM myosin (Fig. 7A). The specific activity at
low F-actin concentration of T-5, whose tail had a substantially lower
affinity for F-actin than wild type tail (Fig. 3), was very much less
at 40 nM than at 141 nM (Fig. 7).
Comparison of Wild Type and Mutant Myosins as Substrates for Myosin
I Heavy Chain Kinase--
As one test of the possible interaction
between the SH3 domain of Acanthamoeba myosin Is and the
PXXP motifs in the proline-rich region of MIHCK, we
determined the Km and Vmax
for the phosphorylation by full-length MIHCK of wild type myosin IC and the T-2 mutant, which lacks the entire tail domain including the SH3
region. The data were very similar for the two substrates (Fig.
8) with a Km of ~6.6
µM and a Vmax of ~15.5
s We have used baculovirus-expressed wild type and truncated and
deletion mutants of Acanthamoeba myosin IC to gain further insights into the ability of the Acanthamoeba myosin Is to
bind to F-actin in the presence of ATP, the unusual triphasic actin dependence of their MgATPase activities and the possibility that the
SH3 domain in the tail of the myosin Is might interact with the PXXP
motifs in the proline-rich region of Acanthamoeba myosin I
heavy chain kinase.
The functions of the SH3 domain of the amoeba myosin Is are not well
understood (18). The SH3 domain binds to the PXXP motif of
Acan125 (42, 43) and to an analogous Dictyostelium protein (44), which may serve as a scaffold for proteins, including myosin Is,
involved in the assembly of the actin cytoskeleton (44). The
observation (45) that Dictyostelium myosin IB lacking the
SH3 domain is unable to rescue the defects in growth and endocytosis of
myosin IB null cells may be the physiological expression of these
biochemical interactions. Similarly, the Saccharomyces
myosin Is have been found to bind through the SH3 domain to the
PXXP regions of verprolin (46, 47) and Bee1p (47, 48),
proteins involved in the assembly of actin, and the SH3 domain is
required for the polymerization of actin (48) and localization of the myosins to actin patches in yeast (46). In contrast to these observations, however, deletion of the SH3 region of
Aspergillus myoA, the only myosin I in this organism, had no
phenotypic effect (49).
Given that the myosin I SH3 domain reacts with the PXXP
motifs of Acan125, that MIHCK has four PXXXPXXP
motifs that are the minimum requirements for interaction of the SH3
domain of Saccharomyces myosin Is with BEEp and verprolin
(47), and that mammalian Pak1 ( The actin-binding data show, as expected, that truncated mutants that
contained only the head domain or only the head and neck domains did
not bind to F-actin in the presence of ATP. Truncated mutants that, in
addition to the head and neck domains, also contained the basic TH-1
domain or the TH-1 domain and all or part of the GPA TH-2 domain did
bind to F-actin in the presence of ATP but not as well as wild type
myosin IC or the deletion mutant, Recently, Lee et al. (5) reported Kd
values of 0.02-0.20 µM for the binding at low ionic
strength of peptides corresponding to Acanthamoeba myosin IA
domains TH-2 and TH-2/3 to Acanthamoeba F-actin and for the
binding of TH-2/3 to rabbit muscle F-actin. The affinities of the
peptides for Acanthamoeba F-actin were unaffected by KCl
concentrations up to 60 mM but the
Kd values of the TH-2-containing peptides for
muscle actin increased to >50 µM in 60 mM
KCl. Peptide TH-1, however, bound to muscle F-actin in 60 mM KCl with Kd ~0.1 µM,
and TH-1 bound to TH-2/3 and enhanced its binding to muscle F-actin in
60 mM KCl.
In our experiments, wild type myosin IC and the The very similar Kd values for wild type and the
Our finding that only wild type myosin and mutant myosins with tail
regions containing one or more ATP-insensitive actin-binding sites
(T-4, T-5, and T-6) exhibit triphasic actin dependence of their
MgATPase activities is consistent with the proposal (17, 19, 21, 22)
that these unusual kinetics are the consequence of the ATP-insensitive
actin-binding site(s) in the tail. The MgATPase activities of two
Dictyostelium myosin Is (23) and rat myr3 (21) have also
been shown to have triphasic actin dependence. Like the
Acanthamoeba myosin Is, Dictyostelium myosin IB
has been shown to have an ATP-insensitive F-actin-binding site in its
tail region (24), but Stöffler and Bähler (52) did not
detect binding of rat myr3 to muscle F-actin in the presence of ATP and concluded, therefore, that a second actin-binding site in the tail is
not responsible for the triphasic kinetics of myr3. However, those
binding studies were done in 150 mM NaCl. At this ionic strength, the amoeba myosin I tails bind very weakly to F-actin and, in
addition, myosins, including myr3 (52), have greatly reduced
actin-dependent MgATPase activity under these
conditions. For these reasons, binding of proteolytically cleaved myr3
to F-actin should be re-evaluated at low ionic strength where the MgATPase activity of myr3 shows maximal triphasic actin dependence (52).
It is interesting that the actin-dependent MgATPase
activities of myosin mutants that lacked some or all of the TH-2 domain (T-4, T-5, and T-6) were lower than the activities of mutants that had
intact TH-1 and TH-2 domains (wild type and We thank Angela Murphy, National Heart, Lung,
and Blood Institute, for synthesizing the FLAG peptide, Dr. Kirsten
Remmert, National Heart, Lung, and Blood Institute, for providing us
the Acanthamoeba actin, and Dr. Christina Tan, National
Heart, Lung, and Blood Institute, for preparing the cDNA for
full-length MIHCK.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, June 5, 2000, DOI 10.1074/jbc.M004287200
2
C. Tan, E. D. Korn, and H. Brzeska,
unpublished data.
The abbreviations used are:
TH, tail homology;
GPA, glycine, proline and alanine-rich;
MIHCK, myosin I heavy chain
kinase;
Pak, p21-activated kinase;
SH3, Src homology 3;
PCR, polymerase
chain reaction;
bp, base pairs;
DTT, dithiothreitol;
BSA, bovine serum
albumin.
Functional Analysis of Tail Domains of Acanthamoeba
Myosin IC by Characterization of Truncation and Deletion Mutants*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
SH3) was
constructed utilizing a unique SanDI site located upstream
of the SH3 domain of myosin IC and an XbaI site in the
vector located downstream of the myosin IC stop codon. Two primers were
synthesized for PCR. The sense primer (primer A),
5'-CGTCCTACGTCGAGGGTCCCCCGCGCGCCG-3' (bp 3134 and 3163 of myosin IC heavy chain) introduced a new SanDI restriction site (underlined) immediately downstream of the SH3 domain.
The antisense primer (primer B) was
5'-GCTCACATGTTCTTTCCTGCGTTATCCCCTGATTC-3' (bp 1128-1162 of pBluescript
II KS+ vector). The original myosin IC plasmid was digested with
SanDI and XbaI, and the PCR product was cloned
between these sites resulting in a deletion of 198 bp, which encode the
amino acids between Pro-986 and Ile-1051 in the myosin IC heavy chain
(bp 2956-3153).
-32P]ATP, phosphorylation was complete (1 mol/mol).
-32P]ATP (30,000 cpm/nmol), 3.5 mM
MgCl2, and 2 mM EGTA and BSA (0.2 mg/ml). At
all substrate concentrations, the rate of phosphorylation was linear
with time for the period of incubation.
-32P]ATP as described (2). The reaction
mixtures for the assay of MgATPase activity contained 20 mM
imidazole, pH 7.5, 4 mM MgCl2, 1 mM
EGTA, 1 mM DTT, 3 mM [
-32P]ATP
(120 cpm/nmol) with or without F-actin as indicated. The reaction
mixtures for the assay of NH4/EDTA-ATPase activity
contained 25 mM Tris (pH 7.5), 400 mM
NH4Cl, 35 mM EDTA, 1 mM DTT, and 3 mM [
-32P]ATP (120 cpm/nmol). The reactions
were started by the addition of myosin at 30 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
SH3, the entire heavy chain except for the deleted SH3
region. The wild type heavy chain and seven mutant heavy chain
constructs were individually co-expressed with the light chain in Sf-9
cells. All of the heavy chains were expressed very well (see Fig.
2, first lane, for expression
of wild type heavy chain). All of the myosins were readily purified by
the procedure described under "Materials and Methods" (Fig. 2),
except for T-3, the mutant that was truncated within the TH-1 domain,
which we were unable to solubilize and, therefore, could not study
further.

View larger version (17K):
[in a new window]
Fig. 1.
Schematic representation of the
Acanthamoeba myosin IC wild type and mutant heavy
chains that were co-expressed with wild type light chain. The
residues are numbered according to the revised sequence
(6).

View larger version (66K):
[in a new window]
Fig. 2.
SDS-polyacrylamide gel electrophoresis
analysis of purified recombinant Acanthamoeba myosin
IC wild type and mutants. The FLAG-tagged T-1, T-2, T-4, T-5, T-6,
and
SH3 mutants and wild type (WT) were purified from the
cell extracts (the extract shown is wild type) in one step using an
anti-FLAG-antibody affinity resin. The T-3 mutant was expressed but was
insoluble and, therefore, could not be purified. The gels were stained
with Coomassie Blue.
SH3 myosins also bound to F-actin in the presence of ATP but T-1
and T-2 did not. T-4, T-5, and T-6 had intermediate behavior. Each
bound extensively to F-actin in the presence of ATP but not as well as
in the absence of ATP. These results are consistent with the recent
report by Lee et al. (5) that bacterially expressed peptides
corresponding to the TH-1, TH-2, and TH-2/3 domains of
Acanthamoeba myosin IA bind to F-actin in the presence of
ATP.

View larger version (93K):
[in a new window]
Fig. 3.
Effect of ATP on the binding of
Acanthamoeba myosin IC wild type and mutants to rabbit
muscle F-actin. Myosin (0.8 µM) in 10 mM
Tris, pH 7.5, 1 mM EGTA, 3.5 mM
MgCl2, 0.2 mg/ml BSA, and 22 mM NaCl (from the
myosin stock solutions) and with or without 10 µM F-actin
and 2 mM ATP was centrifuged for 30 min at 4 °C at
100,000 rpm in a Beckman TL centrifuge. Equivalent amounts of
supernatant (S) and pellet (P) were analyzed by
SDS-polyacrylamide gel electrophoresis.
SH3 mutants in the presence of ATP
(Fig. 4). The measured
Kd values were: wild type, 22 nM;
SH3, 35 nM; T-6, 122 nM; T-5, 120 nM; T-4, 164 nM (Fig. 4). The similar
affinities for F-actin of wild type and
SH3 and of T-6 and T-5 are
consistent with earlier data that the SH3 region is not directly
involved in actin binding. However, the slightly higher
Kd values for the constructs that lack the SH3
domain (
SH3 compared with wild type and T-5 compared with T-6) may
indicate that the SH3 domain has a small modifying effect on binding to F-actin. The higher Kd values for the truncated
mutants T-6, T-5, and T-4 indicate that the GPA2 region (Fig. 1)
contributes significantly to actin binding by the myosin IC tail.

View larger version (28K):
[in a new window]
Fig. 4.
Quantification of the affinities of
Acanthamoeba myosin IC wild type and mutants for
muscle F-actin in the presence of ATP. The conditions were the
same as in Fig. 3 except the myosin concentrations were 40 nM, the F-actin concentrations varied as indicated, and the
buffer contained only 2.5 mM NaCl (from the myosin stock
solutions). The amount of unbound myosin was quantified by assaying the
NH4/EDTA-ATPase activity in the supernatant after
centrifugation at 100,000 rpm in a Beckman TL centrifuge for 30 min at
4 °C. The insets show the same data plotted as the
reciprocal of fraction bound versus the reciprocal of the
free actin concentration.

View larger version (17K):
[in a new window]
Fig. 5.
Effect of NaCl on the binding of Acanthamoeba
myosin IC wild type and T-4 mutant to muscle and
Acanthamoeba F-actin. The binding of 40 nM myosin to 1.125 µM muscle and
Acanthamoeba F-actin at various concentrations of NaCl was
quantified as described in Fig. 4. Wild type and muscle F-actin (
);
wild type and Acanthamoeba F-actin (
); T-4 and muscle
F-actin (
); T-4 and Acanthamoeba F-actin (
). The
amount of bound myosin was determined as described in Fig. 4.
1, as were their NH4/EDTA-ATPase
activities, ~20 s
1 (Table I). Thus, neither deletion
nor truncation within the tail domain affected these basal activities.
SH3 myosins had the triphasic actin dependence
characteristic of native Acanthamoeba myosin Is (Fig.
6A). The actin-dependent MgATPase activities of
the T-4, T-5, and T-6 mutants were qualitatively similar to wild type
(Fig. 6B) but neither the T-1 nor T-2 mutant had significant
MgATPase activity at low actin concentrations (Fig. 6A).
These results are consistent with the earlier proposal that the
triphasic actin-dependent MgATPase activity of the
Acanthamoeba myosin Is results from the ATP-insensitive
actin-binding sites in the tail. However, note that the T-4, T-5, and
T-6 mutants were less active than wild type and
SH3 at low actin
concentration (Fig. 6 and Table I) and less active than wild type,
SH3, T-1, and T-2 at high actin concentrations (Fig. 6 and Table
I).

View larger version (25K):
[in a new window]
Fig. 6.
Actin concentration dependence of the
MgATPase activity of phosphorylated Acanthamoeba
myosin IC wild type and mutants. A, 40.6 nM wild type (
), 40.4 nM
SH3 (
), 92 nM T-2 (
), 90 nM T-1 (
). B,
140 nM T-4 (
), 150 nM T-5 (
), 140 nM T-6 (
). Incubations were for 3 min at 30 °C.
Enzymatic activities of expressed Acanthamoeba myosin IC wild type and
mutants

View larger version (18K):
[in a new window]
Fig. 7.
Effect of myosin concentration on the
triphasic actin dependence MgATPase activity of Acanthamoeba
myosin wild type and T-5 mutants. A, wild type:
120 nM (
), 40 nM type (
). B,
T-5: 141 nM (
), 40 nM (
). Incubations
were for 3 min at 30 °C.
1, indicating that nothing in the myosin I tail,
including the SH3 domain, affects the kinetics of phosphorylation.
Consistent with these results, we found that wild type myosin IC did
not bind to a bacterially expressed peptide corresponding to the entire Pro-rich region of the kinase (data not shown).

View larger version (19K):
[in a new window]
Fig. 8.
Kinetics of the phosphorylation of
Acanthamoeba myosin IC wild type and T-2 mutant by
Acanthamoeba myosin I heavy chain kinase. Wild
type myosin (
) and the T-2 mutant (
) were incubated at the
indicated concentrations with 4.5 nM myosin I heavy chain
kinase (fully activated by autophosphorylation) for 20 s at
30 °C, and the extent of phosphorylation was determined as described
under "Materials and Methods." The maximum concentration of myosin
was limited by its solubility to about 8 µM. The data are
plotted as the reciprocal of the specific activity of the kinase
versus the reciprocal of the myosin concentration. The
insets are direct plots of the same data.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Pak) binds to the SH3 domain of
target proteins (50, 51), it may be surprising that deletion of the SH3
domain from the tail of Acanthamoeba myosin IC had no effect
on the kinetics of its phosphorylation by MIHCK and that wild type
myosin IC did not bind to an expressed peptide that contains the
PXXPXXP motifs of the kinase. However, the
absence of any detectable reaction in vitro between the SH3
domain of myosin IC and the Pro-rich region of MIHCK does not
necessarily preclude such interaction in vivo.
SH3. These data for the myosin IC
mutants are consistent qualitatively with the earlier data for
bacterially expressed peptides (11, 14, 15).
SH3 deletion mutant
(both of which have intact TH-1 and TH-2 regions) had much higher
affinities for muscle F-actin at low ionic strength (Kd values of 22 and 35 nM,
respectively) than Lee et al. (5) found for the TH-1 and
TH-2/3 peptides of Acanthamoeba Myosin IA. The T-6 myosin IC
mutant (which lacks three-fourths of the TH-2 domain), T-5 (which
additionally lacks the TH-3 (SH3) domain), and T-4 (which lacks all of
the TH-2 and TH-3 domains but has all of the TH-1 domain) bound to
muscle F-actin at low ionic strength with Kd
values of 122, 120, and 164 nM, respectively, similar to
the affinities of the expressed myosin IA peptides. Like the myosin IA
peptides, the myosin IC mutants had similar affinities for muscle and
Acanthamoeba F-actin but, unlike the expressed TH-2 and
TH-2/3 myosin IA peptides, binding of the truncated mutants of myosin
IC to both actins was similarly inhibited by ionic strength being
reduced by about 50% in 80-100 mM NaCl and by about 80% in 150 mM NaCl. We do not know if the differences between
our results and the interesting observations of Lee et al.
(5) reflect differences between expressed myosins (this paper) and expressed peptides (5) or between Acanthamoeba myosin IC
(this paper)and Acanthamoeba myosin IA (5).
SH3 myosins and for the T-6 and T-4 constructs indicate, in
agreement with the earlier data for peptides, that the SH3 (TH-3)
domain does not contribute significantly to actin binding. The
substantial difference in the Kd values for
F-actin between wild type myosin and T-6 implies either that the GPA-2
domain binds more tightly than the TH-1 domain or that the TH-1 and
TH-2 domains cooperatively enhance binding of the full-length tail to
F-actin. This latter possibility may be related to the observation by
Lee et al. (5) that the TH-1 peptide bound to the TH-2/3
peptide and increased its affinity for F-actin in 60 mM KCl
by about 50-fold. The small difference in the F-actin affinities of T-4
and T-5 found in our experiments may reflect a contribution of the
GPA-1 domain to the binding of T-5.
SH3) and also of mutants
that lacked the entire tail (T-1 and T-2). Lee et al. (5)
have suggested that the tails of native Acanthamoeba myosin
Is fold back on themselves stabilized by the interaction of the TH-1
and TH-2/3 domains (the expressed peptides interacted with a
Kd of ~250 nM (5)). Possibly, the
absence of any such interaction in the T-4, T-5, and T-6 mutants
allowed the partially truncated tails of these mutants to interfere
with the interaction between F-actin and the catalytic site in the head
domain. In contrast to our results, proteolytic truncation at the C
terminus of rat myr3 was reported to increase its MgATPase activity
(51). We hope that crystallography and cryoelectron microscopy of the
myosin I constructs described in this paper will clarify some of these issues.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
To whom correspondence should be addressed: Laboratory of Cell
Biology, NHLBI, National Institutes of Health, Bldg. 3, Rm. B1-22,
Bethesda, MD 20892. Tel.: 301-496-1616; Fax: 301-402-1519; E-mail:
edk@nih.gov.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Sellers, J. R.
(1999)
Myosins
, Oxford University Press, Oxford
2.
Pollard, T. D.,
and Korn, E. D.
(1973)
J. Biol. Chem.
248,
4682-4690
3.
Jung, G.,
Korn, E. D.,
and Hammer, J. A.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
6720-6724
4.
Jung, G.,
Schmitt, C. J.,
and Hammer, J. A., III
(1989)
Gene (Amst.)
82,
269-280
5.
Lee, W.-L.,
Ostap, E. M.,
Zot, H. G.,
and Pollard, T. D.
(1999)
J. Biol. Chem.
274,
35159-35171
6.
Wang, Z. Y.,
Wang, F.,
Sellers, J. R.,
Korn, E. D.,
and Hammer, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15200-15205
7.
Wang, Z. Y.,
Sakai, J.,
Matsudaira, P. T.,
Baines, I. C.,
Sellers, J. R.,
Hammer, J. A.,
and Korn, E. D.
(1997)
J. Muscle Res. Cell Motil.
18,
395-398
8.
Baines, I. C.,
Brzeska, H.,
and Korn, E. D.
(1992)
J. Cell Biol.
119,
1193-1203
9.
Baines, I. C.,
Corigliano-Murphy, A.,
and Korn, E. D.
(1995)
J. Cell Biol.
130,
591-603
10.
Doberstein, S. K.,
Baines, I. C.,
Wiegand, G.,
Korn, E. D.,
and Pollard, T. D.
(1993)
Nature
365,
841-843
11.
Doberstein, S. K.,
and Pollard, T. D.
(1992)
J. Cell Biol.
117,
1241-1249
12.
Adams, R. J.,
and Pollard, T. D.
(1989)
Nature
340,
505-508
13.
Miyata, H.,
Bowers, B.,
and Korn, E. D.
(1989)
J. Cell Biol.
109,
1519-1528
14.
Jung, G.,
and Hammer, J. A., III
(1994)
FEBS Lett.
342,
197-202
15.
Lynch, T., J.,
Albanesi, J. P.,
Korn, E. D.,
Robinson, E. A.,
Bowers, B.,
and Fujisaki, H.
(1986)
J. Biol. Chem.
261,
17156-17162
16.
Fujisaki, H.,
Albanesi, J. P.,
and Korn, E. D.
(1985)
J. Biol. Chem.
260,
11182-11189
17.
Albanesi, J. P.,
Coué, M.,
Fujisaki, H.,
and Korn, E. D.
(1985)
J. Biol. Chem.
260,
13276-13280
18.
Barylko, B.,
Binns, D. D.,
and Albanesi, J. P.
(2000)
Biochim. Biophys. Acta
1496,
23-25
19.
Brzeska, H.,
Lynch, T. J.,
and Korn, E. D.
(1988)
J. Biol. Chem.
263,
427-435
20.
Lynch, T. J.,
Brzeska, H.,
Miyata, H.,
and Korn, E. D.
(1989)
J. Biol. Chem.
264,
19333-19339
21.
Albanesi, J. P.,
Fujisaki, H.,
and Korn, E. D.
(1985)
J. Biol. Chem.
260,
11174-11179
22.
Pantaloni, D.
(1985)
J. Biol. Chem.
260,
11180-11182
23.
Lee, S. F.,
and Côté, G. P.
(1993)
J. Biol. Chem.
268,
20923-20929
24.
Rosenfeld, S. S.,
and Rener, B.
(1994)
Biochemistry
33,
2322-2328
25.
Hammer, J. A., III,
Albanesi, J. P.,
and Korn, E. D.
(1983)
J. Biol. Chem
258,
10168-10175
26.
Côté, G. P.,
Albanesi, J. P.,
Ueno, T.,
Hammer, J. A., III,
and Korn, E. D.
(1985)
J. Biol. Chem.
260,
4543-4546
27.
Brzeska, H.,
Liu, X.,
Deresso, G.,
Korn, E. D.,
May, G. S.,
and Yamashita, R.
(1999)
Mol. Biol. Cell
10,
161a
28.
Brzeska, H.,
Lynch, T. J.,
Martin, B.,
and Korn, E. D.
(1989)
J. Biol. Chem.
264,
19340-19348
29.
Rayment, I.,
Rypniewski, R. W.,
Schmidt-Bäse, K.,
Smith, R.,
Tomchick, D. R.,
Benning, M. M.,
Winkelmann, D. A.,
Wesenberg, G.,
and Holden, H. M.
(1993)
Science
133,
50-65
30.
Bement, W.,
and Mooseker, M. S.
(1995)
Cell. Motil. Cytoskel.
31,
87-92
31.
Brzeska, H.,
and Korn, E. D.
(1996)
J. Biol. Chem.
271,
16983-16986
32.
Brzeska, H.,
Szczepanowska, J.,
Hoey, J.,
and Korn, E. D.
(1996)
J. Biol. Chem.
271,
27056-27062
33.
Lee, S. F.,
Egelhoff, T. T.,
Mahasneh, A.,
and Côté, G. P.
(1996)
J. Biol. Chem.
271,
27044-27048
34.
Brzeska, H.,
Young, R.,
Knaus, U.,
and Korn, E. D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
394-399
35.
Brzeska, H.,
Lynch, T. J.,
and Korn, E. D.
(1990)
J. Biol. Chem.
265,
3591-3594
36.
Ausubel, F. M.,
Brent, R.,
Kington, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1993)
Current Protocols in Molecular Biology
, Green Publishing Associates, Inc., New York
37.
Spudich, J. A.,
and Watt, S.
(1971)
J. Biol. Chem.
246,
4866-4871
38.
Gordon, D. J.,
Yang, Y. Z.,
and Korn, E. D.
(1976)
J. Biol. Chem.
251,
7474-7479
39.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
40.
Szczepanowska, J. R., U.,
Herring, C. J.,
Gruschus, J. M,
Qin, J.,
Korn, E. D.,
and Brzeska, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4146-4151
41.
Laemmli, U. K.
(1970)
Nature
227,
680-685
42.
Xu, P.,
Zot, A. S.,
and Zot, H. G.
(1995)
J. Biol. Chem.
270,
25316-25319
43.
Xu, P.,
Mitchelhill, K. I.,
Kobe, B.,
Kemp, B. E.,
and Zot, H. G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3685-3690
44.
Jung, G.,
Wu, X.,
and Hammer, J. A., III
(1999)
Mol. Biol. Cell
10,
6a
45.
Novak, K. D.,
and Titus, M. A.
(1998)
Mol. Biol. Cell
9,
75-88
46.
Anderson, B. L.,
Boldogh, I.,
Evangelista, M.,
Boone, C.,
Greene, L. A.,
and Pon, L. A.
(1998)
J. Cell Biol.
141,
1357-1370
47.
Evangelista, M.,
Klebl, B. M.,
Tong, A. H. Y.,
Webb, B. A.,
Leeuw, T.,
Leberer, E.,
Whiteway, M.,
Thomas, D. Y.,
and Boone, C.
(2000)
J. Cell Biol.
148,
353-362
48.
Lechler, T.,
Shevchenko, A.,
Shevchenko, A,
and Li, R.
(2000)
J. Cell Biol.
148,
363-373
49.
Osherov, N.,
Yamashita, R. A.,
Chung, Y. S.,
and May, G. S.
(1998)
J. Biol. Chem.
273,
27017-27025
50.
Lu, W.,
Katz, S.,
Gupta, R.,
and Mayer, B. J.
(1997)
Curr. Biol.
7,
85-94
51.
Manser, E.,
Loo, T. H.,
Koh, C. G.,
Zhao, Z. S.,
Chen, X. G.,
Tan, L.,
Tan, I.,
Leung, T.,
and Lim, L.
(1998)
Mol. Cell
1,
183-192
52.
Stöffler, H. E.,
and Bähler, M.
(1998)
J. Biol. Chem.
273,
14605-14611
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Brzeska, K.-J. Hwang, and E. D. Korn Acanthamoeba Myosin IC Colocalizes with Phosphatidylinositol 4,5-Bisphosphate at the Plasma Membrane Due to the High Concentration of Negative Charge J. Biol. Chem., November 14, 2008; 283(46): 32014 - 32023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Hwang, F. Mahmoodian, J. A. Ferretti, E. D. Korn, and J. M. Gruschus Intramolecular interaction in the tail of Acanthamoeba myosin IC between the SH3 domain and a putative pleckstrin homology domain PNAS, January 16, 2007; 104(3): 784 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Oberholzer, T. L. Iouk, D. Y. Thomas, and M. Whiteway Functional Characterization of Myosin I Tail Regions in Candida albicans Eukaryot. Cell, October 1, 2004; 3(5): 1272 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishikawa, N. Cheng, X. Liu, E. D. Korn, and A. C. Steven Subdomain organization of the Acanthamoeba myosin IC tail from cryo-electron microscopy PNAS, August 17, 2004; 101(33): 12189 - 12194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marion, C. Wilhelm, H. Voigt, J.-C. Bacri, and N. Guillen Overexpression of myosin IB in living Entamoeba histolytica enhances cytoplasm viscosity and reduces phagocytosis J. Cell Sci., July 1, 2004; 117(15): 3271 - 3279. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Korn The Discovery of Unconventional Myosins: Serendipity or Luck? J. Biol. Chem., March 5, 2004; 279(10): 8517 - 8525. [Full Text] [PDF] |
||||
![]() |
G. Tzolovsky, H. Millo, S. Pathirana, T. Wood, and M. Bownes Identification and Phylogenetic Analysis of Drosophila melanogaster Myosins Mol. Biol. Evol., July 1, 2002; 19(7): 1041 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, N. Osherov, R. Yamashita, H. Brzeska, E. D. Korn, and G. S. May Myosin I mutants with only 1% of wild-type actin-activated MgATPase activity retain essential in vivo function(s) PNAS, July 13, 2001; (2001) 161285698. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Gliksman, G. Santoyo, K. D. Novak, and M. A. Titus Myosin I Phosphorylation Is Increased by Chemotactic Stimulation J. Biol. Chem., February 9, 2001; 276(7): 5235 - 5239. [Abstract] [Full Text] [PDF] |
||||
|
|